Announcements

  • All
  • Announcements 2009
  • Announcements 2010
  • Announcements 2011
  • Announcements 2012
  • Announcements 2017
  • Announcements 2018
  • Announcements 2019
  • Announcements 2020
  • Announcements 2021
  • Announcements 2022
  • Announcements 2024

Peania, 15 March 2023 - Lavipharm S.A. announces the key financial figures for 2022 and business developments in its activity: Lavipharm Flash Note FY2022 ...

Peania, 6 March 2023 - Lavipharm S.A, pursuant to articles 4.1.2 & 4.1.3.15.1 of the Athens Stock Exchange Rulebook, announces the Financial Calendar of 2023, as follows : FINANCIAL CALENDAR 2023...

A new page in its presence on the stock exchange Peania, 22 December 2022 – As of Friday, 23 December 2022, the shares of Lavipharm S.A. will be traded again on the Main Market of the Athens Stock Exchange. Following the completion of the share capital increase,...

Peania, 22 December 2022 – As of Friday, 23 December 2022, the shares of Lavipharm S.A. will be traded again on the Main Market of the Athens Stock Exchange. Following the completion of the share capital increase, the Listings and Market Operation Committee of the Athens...

Παιανία, 22 Δεκεμβρίου 2022 - Η «Ανώνυμη Εμπορική και Βιομηχανική Εταιρία Φαρμακευτικών, Χημικών και Καλλυντικών Προϊόντων LAVIPHARM A.E.» (εφεξής «Εταιρεία») ανακοινώνει ότι από την 23.12.2022 θα αρχίσει η διαπραγμάτευση στο Χρηματιστήριο Αθηνών των 150.841.472 νέων κοινών ονομαστικών μετοχών της Εταιρείας, ονομαστικής αξίας 0,30 ευρώ η...

Peania, 20 December 2022 – Lavipharm S.A. share capital increase was completed today with payment in cash and pre-emption rights for existing stockholders. More specifically, €51,286,100.48 was raised, posting a final coverage rate of 88.42%. Major Greek and foreign institutional investors are now participating in the...

Παιανία, 16 Δεκεμβρίου 2022 - Η Εταιρεία «LAVIPHARM Α.Ε.» (εφεξής η «Εταιρεία») γνωστοποιεί προς το επενδυτικό κοινό ότι η Δημόσια Προσφορά από την αύξηση του μετοχικού κεφαλαίου με καταβολή μετρητών και δικαίωμα προτίμησης υπέρ των παλαιών μετόχων Ανακοίνωση  ...

 Athens, 15 November 2022: Tikun Europe, the leading pharmaceutical company in research, development and production of medical cannabis products in Greece, and the Greek pharmaceutical group Lavipharm are entering into a strategic partnership for the distribution of Tikun’s new products, which are anticipated to be...